SOTAC PHARMACEUTICALS
Quarterly Results Analysis [Jun2024]
SOTAC PHARMACEUTICALS Quarterly Results
Consolidated | Jun2024 Audited |
Dec2023 UnAudited |
Jun2023 UnAudited |
Dec2022 UnAudited |
Jun2022 UnAudited |
---|---|---|---|---|---|
Revenues | ₹25 Cr | ₹26 Cr | ₹25 Cr | ₹20 Cr | ₹20 Cr |
Expenses | ₹23 Cr | ₹23 Cr | ₹23 Cr | ₹18 Cr | ₹18 Cr |
Operating Income | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Other Income | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Interest | ₹0 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
Profit Before Tax | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr |
Profit After Tax | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
EPS | ₹1.31 | ₹0.82 | ₹0.98 | ₹0.71 | ₹0.67 |
Industry Peers & Returns | 1W | 1M | 1Y |
SOTAC PHARMACEUTICALS | -2.7% | -13.9% | -19.6% |
SUN PHARMACEUTICAL INDUSTRIES | -5.8% | -3.2% | 35.1% |
CIPLA | -3.9% | -0.5% | 13.9% |
DR REDDYS LABORATORIES | -1.2% | 7.1% | 17.8% |
ZYDUS LIFESCIENCES | -2.7% | -0.1% | 40.9% |
DIVIS LABORATORIES | -2.8% | -3.6% | 44.7% |
MANKIND PHARMA | -11.2% | -2.3% | 33.6% |
TORRENT PHARMACEUTICALS | -4.8% | -2.7% | 40.1% |
LUPIN | -8.6% | 1.8% | 56.9% |
SOTAC PHARMACEUTICALS Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -1.93 % |
Y-o-Y | 27.07 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Jun2024 | ₹25 Cr | -1.93 | |
Dec2023 | ₹26 Cr | 3.11 | |
Jun2023 | ₹25 Cr | 27.05 | |
Dec2022 | ₹20 Cr | -1.10 | |
Jun2022 | ₹20 Cr | - |
SOTAC PHARMACEUTICALS Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -24.07 % |
Y-o-Y | 15.48 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Jun2024 | ₹2 Cr | -24.07 | |
Dec2023 | ₹3 Cr | 24.93 | |
Jun2023 | ₹2 Cr | 31.77 | |
Dec2022 | ₹2 Cr | -7.61 | |
Jun2022 | ₹2 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -22.59 % |
Y-o-Y | -9.12 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Jun2024 | 8.77% | -22.59 | |
Dec2023 | 11.33% | 21.18 | |
Jun2023 | 9.35% | 3.66 | |
Dec2022 | 9.02% | -6.53 | |
Jun2022 | 9.65% | - |
SOTAC PHARMACEUTICALS Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 53.65 % |
Y-o-Y | 150.65 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Jun2024 | ₹1 Cr | 53.65 | |
Dec2023 | ₹1 Cr | -10.98 | |
Jun2023 | ₹1 Cr | 70.83 | |
Dec2022 | ₹1 Cr | 7.26 | |
Jun2022 | ₹1 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 56.76 % |
Y-o-Y | 97.41 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Jun2024 | 5.33 % | 56.76 | |
Dec2023 | 3.4 % | -13.71 | |
Jun2023 | 3.94 % | 34.47 | |
Dec2022 | 2.93 % | 8.52 | |
Jun2022 | 2.7 % | - |
SOTAC PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 59.76 % |
Y-o-Y | 95.52 % |
Quarters | EPS | % Change | |
---|---|---|---|
Jun2024 | ₹1.31 | 59.76 | |
Dec2023 | ₹0.82 | -16.33 | |
Jun2023 | ₹0.98 | 38.03 | |
Dec2022 | ₹0.71 | 5.97 | |
Jun2022 | ₹0.67 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD